Background: This American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Asociación Latinoamericana de Tórax guideline updates prior idiopathic pulmonary fibrosis (IPF) guidelines and addresses the progression of pulmonary fibrosis in patients with interstitial lung diseases (ILDs) other than IPF. Methods: A committee was composed of multidisciplinary experts in ILD, methodologists, and patient representatives. 1) Update of IPF: Radiological and histopathological criteria for IPF were updated by consensus. Questions about transbronchial lung cryobiopsy, genomic classifier testing, antacid medication, and antireflux surgery were informed by systematic reviews and answered with evidence-based recommendations using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach. 2) Progressive pulmonary fibrosis (PPF): PPF was defined, and then radiological and physiological criteria for PPF were determined by consensus. Questions about pirfenidone and nintedanib were informed by systematic reviews and answered with evidence-based recommendations using the GRADE approach. Results: 1) Update of IPF: A conditional recommendation was made to regard transbronchial lung cryobiopsy as an acceptable alternative to surgical lung biopsy in centers with appropriate expertise. No recommendation was made for or against genomic classifier testing. Conditional recommendations were made against antacid medication and antireflux surgery for the treatment of IPF. 2) PPF: PPF was defined as at least two of three criteria (worsening symptoms, radiological progression, and physiological progression) occurring within the past year with no alternative explanation in a patient with an ILD other than IPF. A conditional recommendation was made for nintedanib, and additional research into pirfenidone was recommended. Conclusions: The conditional recommendations in this guideline are intended to provide the basis for rational, informed decisions by clinicians.
To assess noise reduction achievable with an iterative reconstruction algorithm. 32 consecutive chest CT angiograms were reconstructed with regular filtered back projection (FBP) (Group 1) and an iterative reconstruction technique (IRIS) with 3 (Group 2a) and 5 (Group 2b) iterations. Objective image noise was significantly reduced in Group 2a and Group 2b compared with FBP (p < 0.0001). There was a significant reduction in the level of subjective image noise in Group 2a compared with Group 1 images (p < 0.003), further reinforced on Group 2b images (Group 2b vs Group 1; p < 0.0001) (Group 2b vs Group 2a; p = 0.0006). The overall image quality scores significantly improved on Group 2a images compared with Group 1 images (p = 0.0081) and on Group 2b images compared with Group 2a images (p < 0.0001). Comparative analysis of individual CT features of mild lung infiltration showed improved conspicuity of ground glass attenuation (p < 0.0001), ill-defined micronodules (p = 0.0351) and emphysematous lesions (p < 0.0001) on Group 2a images, further improved on Group 2b images for ground glass attenuation (p < 0.0001), and emphysematous lesions (p = 0.0087). Compared with regular FBP, iterative reconstructions enable significant reduction of image noise without loss of diagnostic information, thus having the potential to decrease radiation dose during chest CT examinations.
This systematic review and position paper highlights the key role of imaging in the recognition, workup, treatment planning, and follow-up of pulmonary hypertension. Pulmonary hypertension (PH) is defined by a mean pulmonary artery pressure greater than 20 mm Hg and classified into five different groups sharing similar pathophysiologic mechanisms, hemodynamic c...